BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Case File Statements
DM0000: The mark consists of the text "BRIUMVI" above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" with the "B" in "BRIUMVI" partially surrounded by a sphere edged by a circular line.
PM0002: BRIUMVI UBLITUXIMAB XIIY ONE HUNDRED FIFTY MG PER SIX ML INJECTION FOR IV
PM0001: BRIUMVI UBLITUXIMAB XIIY ONE FIVE ZERO MG PER SIX ML INJECTION FOR IV
CC0000: Color is not claimed as a feature of the mark.
GS0441: Providing health information
DS0000: "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV"
TR0000: The wording BRIUMVI has no meaning in a foreign language.
Case File Event Statements
3/5/2024 - a year ago
1 - NEW APPLICATION ENTEREDType:NWAP
7/18/2024 - 7 months ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSM
7/18/2024 - 7 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
9/18/2024 - 5 months ago
4 - ASSIGNED TO EXAMINERType:DOCK
9/23/2024 - 5 months ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
9/23/2024 - 5 months ago
5 - NON-FINAL ACTION WRITTENType:CNRT
9/23/2024 - 5 months ago
6 - NON-FINAL ACTION E-MAILEDType:GNRT
12/3/2024 - 3 months ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
12/3/2024 - 3 months ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
12/3/2024 - 3 months ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
12/5/2024 - 3 months ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
12/25/2024 - 2 months ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
12/31/2024 - 2 months ago
13 - PUBLISHED FOR OPPOSITIONType:PUBO
12/31/2024 - 2 months ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
2/18/2025 - 17 days ago
15 - REGISTERED-PRINCIPAL REGISTERType:R.PR
2/18/2025 - 17 days ago
16 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC